Recently Launched Antipsychotic Drug

The concept of targeted therapies remains a holy grail for the pharmaceutical drug industry for identifying responder populations or new drug targets. Here we provide quantitative systems pharmacology as an alternative to the more traditional approach of retrospective responder pharmacogenomics analysis and applied this to the case of iloperidone in schizophrenia.

Background

Proposed Quantitative Systems Pharmacology Solution

Outcome: Geerts (2015)